Pharmacokinetics of Opioid Infusions in the Adult Intensive Care Unit Setting—A Systematic Review
- 01.03.2025
- Systematic Review
Erschienen in:
- Verfasst von
- Johannie Beaucage-Charron
- Justine Rinfret
- Guillaume Trottier
- Marie-Maxim Sévigny
- Lisa Burry
- Amélie Marsot
- David Williamson
- Erschienen in
- Clinical Pharmacokinetics | Ausgabe 3/2025
Abstract
Introduction
Pharmacokinetics (PKs) of drugs are often altered in the intensive care unit (ICU). Opioids are often used in the ICU, particularly as continuous infusions, and their characteristics lead them to undergo PK alterations. We conducted a systematic review to assess the PK of opioid infusions in the ICU.
Methods
Embase, MEDLINE, PubMed, CINAHL, and Evidence-Based Medicine Reviews (EBMR) were searched from inception to March 2024. Studies were included if they evaluated PKs of opioid infusions in adult patients in the ICU. Two reviewers independently selected and extracted data.
Results
Out of the 1040 records screened, 17 studies were included. Five studies were conducted on fentanyl, seven on morphine, one on hydromorphone, two on remifentanil, two on alfentanil, and one on sufentanil. Most studies where observational studies or case series. The mean age was 56 years old. Duration of the infusion varied between 3 h and 20 days. PKs of fentanyl, sufentanil, and hydromorphone were significantly impaired, whereas the PKs of morphine, alfentanil, and remifentanil were impaired to a lesser degree. The PK parameter that was most affected by critical illness was the half-life (T½).
Conclusions
To counter these PK alterations, new therapeutic avenues must be further explored in the ICU to individualize opioid infusions.
Anzeige
- Titel
- Pharmacokinetics of Opioid Infusions in the Adult Intensive Care Unit Setting—A Systematic Review
- Verfasst von
-
Johannie Beaucage-Charron
Justine Rinfret
Guillaume Trottier
Marie-Maxim Sévigny
Lisa Burry
Amélie Marsot
David Williamson
- Publikationsdatum
- 01.03.2025
- Verlag
- Springer International Publishing
- Erschienen in
-
Clinical Pharmacokinetics / Ausgabe 3/2025
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926 - DOI
- https://doi.org/10.1007/s40262-025-01490-8
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.